Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the aforementioned active substances with the possibility of conclusion as part of the so-called open-house procedure.
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany · Hannover · how to bid here →
Your path to submission
- Deadline: 31 December at 23:59 — 86 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- 16% of this buyer's awards went to companies that had already won here before (38 awards since 2017, spread over 32 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 38 awards since 2017
- In this sector the buyer awards roughly every 3 months (26 awards, most recently November 2022) — by that rhythm the next award was due around February 2023. The last award went to Blömeke Druck SRS GmbH.n = 26
- The median procedure drew 4 bids (38 procedures with a bid count); 16% ended with a single bidder. Sector: median 2 bids.n = 38
- Not one of the 38 awards with a known winner country has gone to a foreign company so far. Sector average: 1%.n = 38
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,200 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: DEU.
Typical field: median 34 (from 386 awards).
What the buyer is looking for
The aim of the Kaufmännische Krankenkasse - KKH (hereinafter referred to as KKH) is to conclude discount agreements with all suitable pharmaceutical companies pursuant to Section 130a(8) of the German Social Code (SGB V) on the active substance (ATC) referred to in BT-21 Lot and, if necessary, restricting it to certain dosage forms within the framework of a so-called "open house procedure". Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to Paragraph 130a(8) of the SGB V on the above-mentioned active substance. Interested pharmaceutical companies can request the participation documents and the contract from the aforementioned contact address. The prerequisite for the conclusion of a contract…
Show full description
… is that the interested pharmaceutical company submits the requested participation documents in full and signed. A contract is concluded with each pharmaceutical company that meets the requirements for participation. There is no exclusivity. Accession or conclusion of the contract may take place at any time and under the same conditions. Individual contract negotiations are not carried out. If KKH conducts a call for tenders for exclusive contracts in the form of an open procedure during the term of the contract for the active substances, the contracts concluded within the framework of this publication will be terminated in accordance with the contractual provisions.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in German.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| betapharm Arzneimittel GmbH · Augsburg | 8 | 2013–2016 |
| mibe GmbH Arzneimittel · Sandersdorf-Brehna | 8 | 2013–2016 |
| neuraxpharm Arzneimittel GmbH · Langenfeld | 8 | 2013–2016 |
| Basics GmbH · Leverkusen | 8 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 8 | 2013–2016 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.